Skip to main content
Premium Trial:

Request an Annual Quote

Agilent to Invest $25M in India Through 08; Will Expand R&D Staff, Build New Facility

NEW YORK, April 14 (GenomeWeb News) - Agilent Technologies plans to invest $25 million in Indiaover the next two years, CEO Bill Sullivan said yesterday, according to a news report.


Sullivan also said Agilent will build a new campus in the country by 2008, and plans to hire an additional 800 staffers at its facility in Gurgaon, located outside New Delhi. Most of these hires will be in R&D; the facility currently employs around 200 R&D staffers, Reuters reported yesterday from New Delhi.


Sullivan, who spoke to reporters at a press conference in that city, also said he expects revenue generated in the country to triple in two-three years, according to Reuters. Agilent's Indiaoperations generated $100 million in 2005, which represented a 30-percent improvement over 2004, the report said.


Agilent's plans reflect a growing trend among large multi-platform tool vendors, which, like many other kinds of companies, believe markets in Asia, especially Indiaand China, will help them grow revenue.


Most recently, Sigma-Aldrich has increased its operations in Shanghai, China, and acquired Beijing Superior Chemicals and Instruments; PerkinElmer has opened a new technology center in that city and will consolidate three existing facilities there; and Thermo Electron opened a customer demonstration laboratory in Mumbai, India.

The Scan

Shape of Them All

According to BBC News, researchers have developed a protein structure database that includes much of the human proteome.

For Flu and More

The Wall Street Journal reports that several vaccine developers are working on mRNA-based vaccines for influenza.

To Boost Women

China's Ministry of Science and Technology aims to boost the number of female researchers through a new policy, reports the South China Morning Post.

Science Papers Describe Approach to Predict Chemotherapeutic Response, Role of Transcriptional Noise

In Science this week: neural network to predict chemotherapeutic response in cancer patients, and more.